Arena Back on Track with a $33M Equity Financing
BioWorld Today Contributing Writer
Just one day after resubmission of its new drug application for lorcaserin, Arena Pharmaceuticals Inc. is selling nearly 10 million shares of common stock to raise $33 million, demonstrating that it is moving forward following the October 2010 complete response letter from the FDA.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST